Tumult in FDA’s medical device center; one CEO speaks out on NIH cuts
The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled medical technology. Notably, the center has a strained relationship with one of Musk’s companies, Neuralink, which is testing a brain implant. Read more.
Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency ...
The head of the FDA's food division, Jim Jones, resigned on Monday following layoffs within the division that he argues were ...
Scott Whitaker sent a letter to HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S.
The SSA acting commissioner stepped down over requests from DOGE to access data, while the FDA food division head left amid ...
U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...
Drug company executives on Tuesday touted their industry’s work to keep and make Americans healthy during a Washington event.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback